pharma-话题@MedSci

#pharma#

608篇内容 | 2525人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1908534, encodeId=fedb19085345f, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Int Immunopharmacol：没食子酸能减轻过敏性鼻炎模型中的鼻腔炎症, objectType=article, longId=163702, objectId=69dd163e02ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69dd163e02ec, replyNumber=0, likeNumber=77, createdTime=2019-08-25, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69dd163e02ec, moduleTitle=Int Immunopharmacol：没食子酸能减轻过敏性鼻炎模型中的鼻腔炎症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69dd163e02ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908540, encodeId=e5c7190854026, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Front Pharmacol：淫羊藿苷可保护骨髓间充质干细胞免受铁过载诱导的功能障碍, objectType=article, longId=165091, objectId=b20f16509106, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b20f16509106, replyNumber=0, likeNumber=77, createdTime=2020-03-15, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b20f16509106, moduleTitle=Front Pharmacol：淫羊藿苷可保护骨髓间充质干细胞免受铁过载诱导的功能障碍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b20f16509106)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908508, encodeId=dc0819085088a, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Biomed Pharmacother：当心！你的容颜易逝可能是慢性高血糖惹的祸, objectType=article, longId=157938, objectId=a34e15e938d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a34e15e938d5, replyNumber=0, likeNumber=54, createdTime=2019-10-10, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a34e15e938d5, moduleTitle=Biomed Pharmacother：当心！你的容颜易逝可能是慢性高血糖惹的祸, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a34e15e938d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908478, encodeId=517d19084e856, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Eur Rev Med Pharmacol Sci：骨质疏松症患者中提取的骨髓干细胞衍生的外泌体通过microRNA-21/SMAD7抑制骨生成, objectType=article, longId=152847, objectId=7da115284ee6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7da115284ee6, replyNumber=0, likeNumber=74, createdTime=2019-02-02, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7da115284ee6, moduleTitle=Eur Rev Med Pharmacol Sci：骨质疏松症患者中提取的骨髓干细胞衍生的外泌体通过microRNA-21/SMAD7抑制骨生成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7da115284ee6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908546, encodeId=d336190854678, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Int Immunopharmacol：TLR4拮抗剂能够减轻并发过敏性鼻炎和哮喘综合症, objectType=article, longId=167914, objectId=c16616e91458, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c16616e91458, replyNumber=0, likeNumber=66, createdTime=2019-06-10, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c16616e91458, moduleTitle=Int Immunopharmacol：TLR4拮抗剂能够减轻并发过敏性鼻炎和哮喘综合症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c16616e91458)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908492, encodeId=01181908492b2, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Clin Pharmacol Ther：他汀一级预防再获力证不同冠心病风险人群均有获益, objectType=article, longId=156112, objectId=761f15611247, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=761f15611247, replyNumber=0, likeNumber=53, createdTime=2019-05-25, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=761f15611247, moduleTitle=Clin Pharmacol Ther：他汀一级预防再获力证不同冠心病风险人群均有获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=761f15611247)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908559, encodeId=98331908559f2, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Biomed Pharmacother：骨折患者如何预防cox-2特异性抑制剂的副作用, objectType=article, longId=177313, objectId=2cba1e731384, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2cba1e731384, replyNumber=0, likeNumber=57, createdTime=2019-08-21, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2cba1e731384, moduleTitle=Biomed Pharmacother：骨折患者如何预防cox-2特异性抑制剂的副作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2cba1e731384)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908509, encodeId=eaac190850962, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Int Immunopharmacol：蛋氨酸脑啡肽（MENK）对髓样抑制细胞（MDSCs）进行调节的新机制, objectType=article, longId=158554, objectId=b3ba15855463, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3ba15855463, replyNumber=0, likeNumber=65, createdTime=2019-03-10, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3ba15855463, moduleTitle=Int Immunopharmacol：蛋氨酸脑啡肽（MENK）对髓样抑制细胞（MDSCs）进行调节的新机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3ba15855463)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908558, encodeId=a71719085582a, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Eur Rev Med Pharmacol Sci：ROR1-AS1通过靶向Wnt /β-连环蛋白促进结直肠癌的肿瘤发生, objectType=article, longId=177308, objectId=61c21e7308ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61c21e7308ae, replyNumber=0, likeNumber=58, createdTime=2019-12-22, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61c21e7308ae, moduleTitle=Eur Rev Med Pharmacol Sci：ROR1-AS1通过靶向Wnt /β-连环蛋白促进结直肠癌的肿瘤发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61c21e7308ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908518, encodeId=afeb190851802, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Eur Rev Med Pharmacol Sci：MiR-146a调节创伤性股骨头坏死中骨髓基质细胞的成骨分化和增殖, objectType=article, longId=159565, objectId=7c6a15956560, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c6a15956560, replyNumber=0, likeNumber=62, createdTime=2019-05-14, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c6a15956560, moduleTitle=Eur Rev Med Pharmacol Sci：MiR-146a调节创伤性股骨头坏死中骨髓基质细胞的成骨分化和增殖, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c6a15956560)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908510, encodeId=fbeb1908510e2, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=FDA批准MGB Biopharma的新型抗生素IND申请治疗艰难梭菌相关性腹泻, objectType=article, longId=158875, objectId=0f461588e508, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f461588e508, replyNumber=0, likeNumber=62, createdTime=2019-09-24, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f461588e508, moduleTitle=FDA批准MGB Biopharma的新型抗生素IND申请治疗艰难梭菌相关性腹泻, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f461588e508)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908511, encodeId=5b481908511e8, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Eur Rev Med Pharmacol Sci：miR-339的下调通过靶向DLX5促进BMSC的分化并改善骨质疏松症, objectType=article, longId=159002, objectId=515c159002e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=515c159002e4, replyNumber=0, likeNumber=50, createdTime=2019-11-27, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=515c159002e4, moduleTitle=Eur Rev Med Pharmacol Sci：miR-339的下调通过靶向DLX5促进BMSC的分化并改善骨质疏松症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=515c159002e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908536, encodeId=55c21908536a4, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Front Pharmacol：基于洛匹那韦/利托那韦的**和替代二线方案在HIV感染患者中的疗效, objectType=article, longId=164255, objectId=4e0616425517, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e0616425517, replyNumber=0, likeNumber=54, createdTime=2019-08-13, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e0616425517, moduleTitle=Front Pharmacol：基于洛匹那韦/利托那韦的**和替代二线方案在HIV感染患者中的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e0616425517)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908477, encodeId=86c019084e75f, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Fundam Clin Pharmacol：研究揭示氟西汀对人脂肪干细胞增殖和分化的影响, objectType=article, longId=152595, objectId=df7215259550, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df7215259550, replyNumber=0, likeNumber=87, createdTime=2019-09-20, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df7215259550, moduleTitle=Fundam Clin Pharmacol：研究揭示氟西汀对人脂肪干细胞增殖和分化的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df7215259550)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908547, encodeId=587d190854e76, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Front Pharmacol：氯化铷可用于植入物表面涂层促进骨整合, objectType=article, longId=168540, objectId=a263168540ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a263168540ab, replyNumber=0, likeNumber=70, createdTime=2019-08-15, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a263168540ab, moduleTitle=Front Pharmacol：氯化铷可用于植入物表面涂层促进骨整合, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a263168540ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908500, encodeId=c2e9190850086, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Pharmacotherapy：急症患者万古霉素联合哌拉西林-他唑巴坦急性肾损伤风险增加6.8倍, objectType=article, longId=156870, objectId=54441568e050, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54441568e050, replyNumber=0, likeNumber=69, createdTime=2019-02-26, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54441568e050, moduleTitle=Pharmacotherapy：急症患者万古霉素联合哌拉西林-他唑巴坦急性肾损伤风险增加6.8倍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54441568e050)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908555, encodeId=ad8d190855599, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Pharmacology：萝卜硫素可逆转氧化应激对成骨细胞活性和矿化的抑制作用, objectType=article, longId=176577, objectId=2b9d1e65771e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b9d1e65771e, replyNumber=0, likeNumber=52, createdTime=2020-01-03, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b9d1e65771e, moduleTitle=Pharmacology：萝卜硫素可逆转氧化应激对成骨细胞活性和矿化的抑制作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b9d1e65771e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908465, encodeId=67a8190846584, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Ferring Pharmaceuticals在英国推出睾酮替代疗法Testavan治疗性腺功能减退, objectType=article, longId=149625, objectId=38d4149625b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38d4149625b6, replyNumber=0, likeNumber=72, createdTime=2019-01-08, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38d4149625b6, moduleTitle=Ferring Pharmaceuticals在英国推出睾酮替代疗法Testavan治疗性腺功能减退, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=38d4149625b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908527, encodeId=79c8190852e3d, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Glenmark Pharmaceuticals在美国皮肤病学会年会上介绍GBR 830（抗OX40单抗）的2a期临床数据, objectType=article, longId=161549, objectId=c3c3161549aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3c3161549aa, replyNumber=0, likeNumber=58, createdTime=2019-10-30, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3c3161549aa, moduleTitle=Glenmark Pharmaceuticals在美国皮肤病学会年会上介绍GBR 830（抗OX40单抗）的2a期临床数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3c3161549aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908497, encodeId=a613190849edb, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Clin Exp Pharmacol Physiol：MicroRNA let-7c-5p通过HMGA2/PI3K/Akt信号阻断抑制脂多糖诱导的炎症, objectType=article, longId=156806, objectId=6259156806cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6259156806cb, replyNumber=0, likeNumber=66, createdTime=2019-09-15, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6259156806cb, moduleTitle=Clin Exp Pharmacol Physiol：MicroRNA let-7c-5p通过HMGA2/PI3K/Akt信号阻断抑制脂多糖诱导的炎症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6259156806cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

pharma

2020-05-29

chentianping (审核中...)

前往app查看评论内容

#pharma#

Int Immunopharmacol：没食子酸能减轻过敏性鼻炎模型中的鼻腔炎症

2019-08-25

chentianping (审核中...)

前往app查看评论内容

#pharma#

Front Pharmacol：淫羊藿苷可保护骨髓间充质干细胞免受铁过载诱导的功能障碍

2020-03-15

chentianping (审核中...)

前往app查看评论内容

#pharma#

Biomed Pharmacother：当心！你的容颜易逝可能是慢性高血糖惹的祸

2019-10-10

chentianping (审核中...)

前往app查看评论内容

#pharma#

Eur Rev Med Pharmacol Sci：骨质疏松症患者中提取的骨髓干细胞衍生的外泌体通过microRNA-21/SMAD7抑制骨生成

2019-02-02

chentianping (审核中...)

前往app查看评论内容

#pharma#

Int Immunopharmacol：TLR4拮抗剂能够减轻并发过敏性鼻炎和哮喘综合症

2019-06-10

chentianping (审核中...)

前往app查看评论内容

#pharma#

Clin Pharmacol Ther：他汀一级预防再获力证不同冠心病风险人群均有获益

2019-05-25

chentianping (审核中...)

前往app查看评论内容

#pharma#

Biomed Pharmacother：骨折患者如何预防cox-2特异性抑制剂的副作用

2019-08-21

chentianping (审核中...)

前往app查看评论内容

#pharma#

Int Immunopharmacol：蛋氨酸脑啡肽（MENK）对髓样抑制细胞（MDSCs）进行调节的新机制

2019-03-10

chentianping (审核中...)

前往app查看评论内容

#pharma#

Eur Rev Med Pharmacol Sci：ROR1-AS1通过靶向Wnt /β-连环蛋白促进结直肠癌的肿瘤发生

2019-12-22

chentianping (审核中...)

前往app查看评论内容

#pharma#

Eur Rev Med Pharmacol Sci：MiR-146a调节创伤性股骨头坏死中骨髓基质细胞的成骨分化和增殖

2019-05-14

chentianping (审核中...)

前往app查看评论内容

#pharma#

FDA批准MGB Biopharma的新型抗生素IND申请治疗艰难梭菌相关性腹泻

2019-09-24

chentianping (审核中...)

前往app查看评论内容

#pharma#

Eur Rev Med Pharmacol Sci：miR-339的下调通过靶向DLX5促进BMSC的分化并改善骨质疏松症

2019-11-27

chentianping (审核中...)

前往app查看评论内容

#pharma#

Front Pharmacol：基于洛匹那韦/利托那韦的**和替代二线方案在HIV感染患者中的疗效

2019-08-13

chentianping (审核中...)

前往app查看评论内容

#pharma#

Fundam Clin Pharmacol：研究揭示氟西汀对人脂肪干细胞增殖和分化的影响

2019-09-20

chentianping (审核中...)

前往app查看评论内容

#pharma#

Front Pharmacol：氯化铷可用于植入物表面涂层促进骨整合

2019-08-15

chentianping (审核中...)

前往app查看评论内容

#pharma#

Pharmacotherapy：急症患者万古霉素联合哌拉西林-他唑巴坦急性肾损伤风险增加6.8倍

2019-02-26

chentianping (审核中...)

前往app查看评论内容

#pharma#

Pharmacology：萝卜硫素可逆转氧化应激对成骨细胞活性和矿化的抑制作用

2020-01-03

chentianping (审核中...)

前往app查看评论内容

#pharma#

Ferring Pharmaceuticals在英国推出睾酮替代疗法Testavan治疗性腺功能减退

2019-01-08

chentianping (审核中...)

前往app查看评论内容

#pharma#

Glenmark Pharmaceuticals在美国皮肤病学会年会上介绍GBR 830（抗OX40单抗）的2a期临床数据

2019-10-30

chentianping (审核中...)

前往app查看评论内容

#pharma#

Clin Exp Pharmacol Physiol：MicroRNA let-7c-5p通过HMGA2/PI3K/Akt信号阻断抑制脂多糖诱导的炎症

2019-09-15

科室
- - 订阅+
  - 更多科室
工具
服务